• Wed, May 5, 2021

Robert Burns Maintained (ATRA) at Strong Buy with Decreased Target to $775 on, May 5th, 2021

Robert Burns of HC Wainwright & Co., Maintained "Atara Biotherapeutics, Inc." (ATRA) at Strong Buy with Decreased Target from $800 to $775 on, May 5th, 2021.

Robert, nor any peers, have made any analyst calls on ATRA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30